News
UnitedHealth Group said 2025 revenue at Optum would be $10 billion less than previously estimated. Now the company is saying ...
The change marks a shift in the Food and Drug Administration’s policy on approving COVID-19 vaccines, which the new ...
Regeneron has been busy, with two health tech deals announced this week: One is about genetic data and one about AI. Both of ...
Online weight loss company Noom has begun offering smaller doses of compounded versions of Novo Nordisk's Wegovy ...
The FDA originally approved Otulfi as a biosimilar in October 2024 based on clinical data that demonstrated the product was ...
The FDA has approved Optison for use in pediatric patients with suboptimal echocardiograms to opacify the left ventricle and to improve the delineation of the left ventricle endocardial borders.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results